Raffi Asadorian
2017 - Amyris
In 2017, Raffi Asadorian earned a total compensation of $469.9K as Former Chief Financial Officer at Amyris, a 24% decrease compared to previous year.
Compensation breakdown
| Salary | $24,586 |
|---|---|
| Other | $445,300 |
| Total | $469,886 |
Asadorian received $445.3K in other compensation, accounting for 95% of the total pay in 2017.
Asadorian also received $24.6K in salary.
Rankings
In 2017, Raffi Asadorian's compensation ranked 12,072nd out of 14,666 executives tracked by ExecPay. In other words, Asadorian earned more than 17.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,072 out of 14,666 | 18th |
Division Manufacturing | 4,758 out of 5,772 | 18th |
Major group Chemicals And Allied Products | 1,737 out of 2,075 | 16th |
Industry group Industrial Organic Chemicals | 59 out of 70 | 16th |
Source: SEC filing on April 27, 2018.
Asadorian's colleagues
We found five more compensation records of executives who worked with Raffi Asadorian at Amyris in 2017.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019